Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 9Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Leukemia 7Myelodysplastic Syndromes 5Primary Myelofibrosis 3Polycythemia Vera 3Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Thrombocythemia, Essential 1Splenomegaly 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Iron Deficiencies 1Anemia, Aplastic 1Anemia 1

Interventions

Cyclophosphamide 47fludarabine phosphate 46Peripheral Blood Stem Cell Transplantation 36Tacrolimus 34Antilymphocyte Serum 33Busulfan 32Mycophenolic Acid 31Filgrastim 24Cyclosporine 24Radiotherapy 22Methotrexate 20Whole-Body Irradiation 18Methylprednisolone 18Melphalan 18Cord Blood Stem Cell Transplantation 14fludarabine 12Etoposide 11Granulocyte Colony-Stimulating Factor 8sargramostim 7Alemtuzumab 7Sirolimus 6Psychiatric Rehabilitation 6Flow Cytometry 6Cytarabine 6Rituximab 4Prednisone 4Polymerase Chain Reaction 4Immunologic Techniques 4thymoglobulin 3Thiotepa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Surveys and Questionnaires × Myeloid × Clear all
NCT01875237 2019-07-16

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

M.D. Anderson Cancer Center

Phase 1/2 Terminated
3 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡